ADAR1 Capital Management »

Bausch Lomb Corp shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Bausch Lomb Corp (BLCO) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Bausch Lomb Corp

Tip: Access up to 7 years of quarterly data

All positions including Bausch Lomb Corp held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bausch Lomb Corp by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $92k 5.3k 17.30
2023-12-31 $60k 3.5k 17.06

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Bausch Lomb Corp

GoldenTree Asset Management
Maple Rock Capital Partners
Carl C. Icahn, Individual
Alberta Investment Management Corporation
River Road Asset Management
D. E. Shaw & Co
Apollo Management Holdings
Nomura Holdings
Whitebox Advisors
Empyrean Capital Partners
Laurion Capital Management
ExodusPoint Capital Management
Canada Pension Plan Investment Board
Arrowstreet Capital, Limited Partnership
King Street Capital Management

View all funds holding Bausch Lomb Corp